Results 171 to 180 of about 1,055,250 (236)

Anticholinergic burden and its predictors among patients with schizophrenia in Northwest Ethiopia: An institutional-based cross sectional study. [PDF]

Ther Adv Psychopharmacol
Tamene FB, Tarekegn GY, Moges TA, Dagnew SB, Zerihun TE, Kassaw AT, Mussie DA, Zewdu WS, Wondm SA.   +8 more
europepmc   +1 more source

Medication Burden: Beyond Counts to Recognize Polypharmacy as an Inherent Part of Living With Chronic Kidney Disease. [PDF]

Basic Clin Pharmacol Toxicol
Houlind MB, Juul-Larsen HG, Strandhave C, Westergaard N, Olesen AE.   +4 more
europepmc   +1 more source

Adverse Drug Reaction Trajectories in Older Adults: From Pharmacological Vulnerability to Clinical Complexity. [PDF]

Int J Environ Res Public Health
Lauretani F, Testa C, Salvi M, Zucchini I, Merolla A, Rovere-Querini P, Maggio M.   +6 more
europepmc   +1 more source

Response to "Comment on cognitive function in the context of pharmacogenetic CYP2D6 variability and anticholinergic burden in older adults - results from the ActiFE study". [PDF]

Eur J Clin Pharmacol
Lorenz L, Berres J, Denkinger MD, Rothenbacher D, Braig S, Dallmeier D, Just KS.   +6 more
europepmc   +1 more source

Exploratory prescribing risk profiles and drug drug interaction burden in older adults with depressive episodes. [PDF]

Front Psychiatry
Goldiş FD, Ardelean SM, Udrescu L.
europepmc   +1 more source

Potentially inappropriate prescribing in Iranian elderly population: a nationwide claims-based analysis. [PDF]

BMJ Open
Kharaghani MA, Kianipour R, Ataei SM, Ebrahimpour S, Shahali Z, Golestani A, Tabatabaei-Malazy O.   +6 more
europepmc   +1 more source

Anticholinergic Burden at Admission and Discharge Among Geriatric Inpatients: A Single-Center Retrospective Cohort Study. [PDF]

Int J Gen Med
Akhtar A, Balquis F, Jamshed S, Asim Z, Sivanandy P, Mohamed Ibrahim MI, Aslam A, Arain MI, Iqbal A, Syed W, Al-Rawi MBA, Alqahtani N.   +11 more
europepmc   +1 more source

The cross-sectional association of frailty with past and current exposure to strong anticholinergic drugs

Aging Clinical and Experimental Research, 2020
Background Anticholinergic drugs may contribute to frailty by impairing cognitive and physical functions. Strong anticholinergic drugs in particular may have adverse effects among older adults. Objectives Determine the association between frailty and the
Michael J Mintzer, Dhanya Baskaran, Jorge G. Ruiz, MD   +2 more
exaly   +2 more sources